Lilly Biotechnology Center campus of an American pharmaceutical company Eli Lilly and Company

Michael Vi

A US judge on Monday denied Novo Nordisk’s (NVO) bid to halt Eli Lilly’s (LLY) weight-loss drug advertisements, which the Danish pharmaceutical company alleged were false and misleading, in a market generating tens of billions of dollars in annual sales.

Source link

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading